Phenominer Database Results (6 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
SPRD/Ztm mammary tumor growth rate 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 97 days-118 days 48 0.7 cm/week 0.0 0.03 unspecified method 0.0 DMBA oral gavage 0 the first 3 weeks of tumor growth 11346 73
SPRD/Ztm mammary gland terminal end bud count control condition Lella V, et al., Int J Cancer. 2007 Oct 15;121(8):1738-43. mammary gland development trait female 55 days 5 84.6 null 12.4 27.73 ex vivo light microscopy 0 0 66135 709
SPRD/Ztm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 17 10.89 null 0.43 1.77 manual palpation method 0 DMBA oral gavage 133 days 11354 74
SPRD/Ztm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 186 days-191 days 48 11.23 null 0.07 0.51 necropsy 0 DMBA oral gavage 0 necropsy 11340 73
SPRD/Ztm post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 97 days-102 days 48 43.8 d 0.13 0.9 manual palpation method 0 DMBA oral gavage 0 11343 73
SPRD/Ztm mammary tumor growth rate 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 25 0.72 cm/week 0.04 0.2 unspecified method 0 DMBA oral gavage 0 the first 3 weeks of tumor growth 11509 74